Genus Capital Management Inc. Novo Nordisk A S Put Options Transaction History

Genus Capital Management Inc.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Oct 29, 2024	SELL	$119.07 - $145.42 $191,464 - $233,835	-1,608 Reduced 11.54%	12,321 $1.47 Billion
Q2 2024 Aug 09, 2024	BUY	$122.71 - $146.91 $1.71 Million - $2.05 Million	13,929 New	13,929 $1.99 Billion
Q4 2023 Feb 06, 2024	BUY	$87.78 - $105.45 $1.56 Million - $1.88 Million	17,782 New	17,782 $1.84 Billion

1,956

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $239B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Genus Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Genus Capital Management Inc. with notifications on news.